BEAM incurs a narrower-than-expected loss in the fourth quarter. The company remains focused on pipeline development.

Full Year 2024 Results Key Financial Results Revenue: US$63.5m (down 83% from ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on Beam Therapeutics (BEAM – Research Report), with a price target ...

In a report released yesterday, Luca Issi from RBC Capital maintained a Hold rating on Beam Therapeutics (BEAM – Research Report), with a price ...

While radiation therapy has been in use for more than 100 years, innovations including linear accelerators, imaging, and AI ...

Physiotherapist Igor Simoes Andrade, 49, who says his special form of animal therapy is "the first in the world," is not a ...

In collaboration with Hitachi, the National Cancer Centre Singapore has introduced Proton Beam Therapy - a treatment designed to target tumours with precision while reducing the impact on healthy ...

Madrigal Pharmaceuticals MDGL reported fourth-quarter 2024 loss of $2.71 per share, narrower than the Zacks Consensus ...

BRAVE Holly Worswick thought her recurrent headaches were from not drinking enough water. But after she claims her GP blamed ...

"The optician gave me a letter and said I need to go to A&E now and get a CT and MRI scan. They told me about the mass later ...

One of the youngest victims of proposed NIH funding cuts would be six-year-old Cailen Vela of Michigan, who has a rare and ...